161 related articles for article (PubMed ID: 8893069)
21. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
Nahata MC; Morosco RS; Trowbridge JM
Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
[TBL] [Abstract][Full Text] [Related]
22. Stability of sumatriptan succinate in extemporaneously prepared oral liquids.
Fish DN; Beall HD; Goodwin SD; Fox JL
Am J Health Syst Pharm; 1997 Jul; 54(14):1619-22. PubMed ID: 9248606
[TBL] [Abstract][Full Text] [Related]
23. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
Zhang YP; Trissel LA; Fox JL
Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
[TBL] [Abstract][Full Text] [Related]
24. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
Levinson ML; Johnson CE
Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
[TBL] [Abstract][Full Text] [Related]
25. Stability of sotalol hydrochloride in extemporaneously prepared oral suspension formulations.
Sidhom MB; Rivera N; Almoazen H; Taft DR; Kirschenbaum HL
Int J Pharm Compd; 2005; 9(5):402-6. PubMed ID: 23925139
[TBL] [Abstract][Full Text] [Related]
26. Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP; Johnson CE; Lee J; Currie K
Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
[TBL] [Abstract][Full Text] [Related]
27. Stability of nifedipine in two oral suspensions stored at two temperatures.
Nahata MC; Morosco RS; Willhite EA
J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
[TBL] [Abstract][Full Text] [Related]
28. Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin YS; Lin SC; Hsieh YT; Liu LY; Lin CH; Shen LJ; Huang CF
Eur J Hosp Pharm; 2022 Nov; 29(6):324-328. PubMed ID: 33608396
[TBL] [Abstract][Full Text] [Related]
29. Stability of lisinopril in two liquid dosage forms.
Nahata MC; Morosco RS
Ann Pharmacother; 2004 Mar; 38(3):396-9. PubMed ID: 14742834
[TBL] [Abstract][Full Text] [Related]
30. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
[TBL] [Abstract][Full Text] [Related]
31. Stability of levofloxacin in an extemporaneously compounded oral liquid.
VandenBussche HL; Johnson CE; Fontana EM; Meram JM
Am J Health Syst Pharm; 1999 Nov; 56(22):2316-8. PubMed ID: 10582824
[TBL] [Abstract][Full Text] [Related]
32. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
[TBL] [Abstract][Full Text] [Related]
33. Stability of extemporaneously compounded spironolactone suspensions.
Mathur LK; Wickman A
Am J Hosp Pharm; 1989 Oct; 46(10):2040-2. PubMed ID: 2816959
[TBL] [Abstract][Full Text] [Related]
34. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
Cober MP; Johnson CE
Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
[TBL] [Abstract][Full Text] [Related]
35. Stability of tacrolimus in an extemporaneously compounded oral liquid.
Jacobson PA; Johnson CE; West NJ; Foster JA
Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
[TBL] [Abstract][Full Text] [Related]
36. Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.
Das Gupta V; Gibbs CW; Ghanekar AG
Am J Hosp Pharm; 1978 Nov; 35(11):1382-5. PubMed ID: 568384
[TBL] [Abstract][Full Text] [Related]
37. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
38. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children.
Pramann LA; Davidow LW; van Haandel L; Funk RS
Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668
[TBL] [Abstract][Full Text] [Related]
39. Stability of dolasetron in two oral liquid vehicles.
Johnson CE; Wagner DS; Bussard WE
Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
[TBL] [Abstract][Full Text] [Related]
40. Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
Metras JI; Swenson CF; McDermott MP
Am J Hosp Pharm; 1992 Jul; 49(7):1720-4. PubMed ID: 1621730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
